.jpg "Pharma Manufacturing Solutions and Services Provider")
India's Role in Shaping the Future of Oncology and Immunology
Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine,...
In an exclusive interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine, India & South Asia, discusses how...
India's 30% Anti-Cancer Drug Margin Cap: What...
Fathimanoud, Correspondent, India Pharma Outlook
India’s 30% anti-cancer drug margin cap targets lower cancer medicine prices, promising patient savings while reshaping pharmaceutical and hospital...
Advancements in Computer-Aided Drug Design for...
Computer aided drug design (CADD) has played a pivotal role in...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
India's Role in Shaping the Future of Oncology and Immunology
In an exclusive interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine, India & South Asia, discusses how...
Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine,...
Building Scalable MedTech Ecosystem for India's Healthcare Future
Dr. Anudeep Sandhu, Director - Medical Affairs & Clinical Affairs, Terumo India
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook magazine, Dr. Anudeep Sandhu, Director, Medical and Clinical Affairs,...
Why Clinical Evidence Matters More in MedTech Commercialization
Anil Suri, Chief Commercial Officer, Sahajanand Medical Technologies
In an exclusive conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook magazine, Anil Suri, Chief Commercial Officer, Sahajanand...
How Deviation Trends Can Reveal Hidden Pharma Quality Risks
Jayakumar A V, President (Quality), Ajanta Pharma Ltd
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Jayakumar A V, President (Quality), Ajanta Pharma Ltd, discusses how...
Most Viewed
India's 30% Anti-Cancer Drug Margin Cap: What...
Fathimanoud, Correspondent, India Pharma Outlook
India’s 30% anti-cancer drug margin cap targets lower cancer medicine prices, promising patient savings while reshaping pharmaceutical and hospital...
Telemedicine for Senior Chronic Care: Clinical Guidelines and Remote Care...
Fathimanoud, Correspondent, India Pharma Outlook
Telemedicine is transforming senior chronic care through remote monitoring, virtual...
India's Drug Pricing Architecture: Why the Rules Keep Expanding
Fathimanoud, Correspondent, India Pharma Outlook
India’s Drug Pricing Architecture is evolving as regulators expand price controls,...
World Heart Day 2026: 8 Ways to Protect Your Heart Every Day
Fathimanoud, Correspondent, India Pharma Outlook
World Heart Day 2026 highlights eight practical ways to protect heart health through daily...
Advancements in Computer-Aided Drug Design for...
Computer aided drug design (CADD) has played a pivotal role in...
The Future of Kidney Transplants in India
A milestone has been achieved by Fortis Hospital, Bengaluru...
Why India is Gaining Popularity for Clinical Trials
India has successfully performed the first human clinical...
.jpg "Usage of Conversational AI in the Health Insurance Sector")
Usage of Conversational AI in the Health Insurance Sector
At the Conversational AI and Customer Experience summit last...